News

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, today announced its continued partnership with the Heart Rhythm Society and support of the Max Schaldach Fellowship Award in Cardiac Pacing and Electrophysiology. In its...

Catheter-based renal denervation, a minimally invasive procedure that delivers tiny radiofrequency pulses via electrodes to the walls of the kidney arteries, is projected to improve blood pressure and substantially reduce the incidence of...

Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced that it will be extending its offered services with comprehensive inherited cardiovascular disease...

BIOTRONIK continues 50-year legacy of engineering excellence with smaller, thinner ICD/CRT-D, including the unique DX platform BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug...

Scientific Session Presentations Feature Laser Balloon Ablation as Single Procedure Treatment for Atrial Fibrillation CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF),...

Continuum Cardiovascular Centers of New York is pleased to announce the appointment of Andrea Natale, MD, a world renowned leader in the field of interventional cardiac electrophysiology, as the Executive Director of the Al-Sabah Arrhythmia...

Electrophysiology (EP) clinical teams require a unique set of technologies to perform accurate and safe exams. Toshiba America Medical Systems, Inc. offers these clinicians an InfinixTM-i cardiovascular X-ray system tailored for EP procedures...

-Bristol-Myers Squibb Company and Pfizer Inc. today announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this...

Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva® portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera® portfolio...

The MultiPoint Pacing study is designed to show improved effectiveness for patients when pacing multiple locations of the heart St. Jude Medical, Inc., a global medical device company, today announced first enrollment of its MultiPoint™...